| Peer-Reviewed

Expression of Metallothioneins in Placental and Fetal Tissues in Undisturbed and PGM-Zn Treated Syngeneic Pregnancy

Received: 16 January 2015    Accepted: 19 January 2015    Published: 2 March 2015
Views:       Downloads:
Abstract

Metallothioneins (MTs) are cysteine-rich proteins, which have been implicated in regulation of physiological processes, such as cell growth, repair, differentiation, apoptosis and immunoregulation, as well as in the protection against heavy metals, oxidant damages, inflammation and other stressful conditions. To investigate their roles in physiological and detoxification processes at the maternal-fetal interface and in fetal organogenesis we examined the tissue expression of MT I/II isoforms in undisturbed syngeneic pregnancy and after the treatment with peptidoglycan monomer linked with zinc (PGM-Zn). The data showed that in undisturbed pregnancy the MTs were highly expressed at junctional zone of placenta, on endovascular trophoblast giant cells, glycogen cells and spongiotrophoblast cells, as well as on villous trophoblast cells. In the fetus they were found predominantly in the liver and in epithelial tissues, such as intestine, pancreas and kidney. Treatment with PGM-Zn markedly enhanced the intensity of MT staining both at the maternal-fetal interface and in fetal organs. The data imply that MTs are involved in the protection of trophoblast cells against the pregnancy-induced deregulation of redox and neuro-immuno-endocrine homeostasis, in transport and storage of essential metals required for fetal organogenesis, as well as in the protection of fetus against bacterial toxins.

Published in American Journal of BioScience (Volume 3, Issue 2-2)

This article belongs to the Special Issue Oxidants-Antioxidants, The Biological Balance

DOI 10.11648/j.ajbio.s.2015030202.12
Page(s) 1-7
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Metallothionein I/II, Peptidoglycan Monomer Linked with Zinc, Syngeneic Pregnancy, Feto-Placental Unit, Fetal Organogenesis

References
[1] J. C. Cross, "How to make a placenta: Mechanisms of trophoblast cell differentiation in mice - A Review," Placenta, vol. 26, pp. S3-S9, 2005.
[2] B. A. Croy, S. Esadeg, S. Chantakru, M. van den Heuvel, V. A. Paffaro Jr, H. He, G. P. Black, A. A. Ashkar, Y. Kiso, and J. Zhang, "Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus," Journal of Reproductive Immunology, vol. 59, pp. 175-191, 2003.
[3] L. K. Harris, "Review: Trophoblast-Vascular Cell Interactions in Early Pregnancy: How to Remodel a Vessel," Placenta, vol. 31, pp. S93-S98, 2010.
[4] P. Le Bouteiller and J. Tabiasco, "Killers become builders during pregnancy," Nat Med, vol. 12, pp. 991-992, 2006.
[5] J. K. Riley, "Trophoblast Immune Receptors in Maternal-Fetal Tolerance." vol. 37: Immunological Investigations, 2008, pp. 395-426.
[6] D. Rukavina and E. R. Podack, "Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?," Immunol Today, vol. 21, pp. 160-3, Apr 2000.
[7] J. Szekeres-Bartho, "Immunological relationship between the mother and the fetus," Int Rev Immunol, vol. 21, pp. 471-95, Nov-Dec 2002.
[8] D. A. Clark, G. Chaouat, K. Wong, R. M. Gorczynski, and R. Kinsky, "Tolerance mechanisms in pregnancy: a reappraisal of the role of class I paternal MHC antigens," Am J Reprod Immunol, vol. 63, pp. 93-103, Feb 2010.
[9] K. Galazka, K. Pitynski, J. Skret-Magierlo, P. Mach, A. Knafel, J. Sikora, T. Niemiec, J. Dobrogowski, A. Basta, and L. Wicherek, "The increase in metallothionein and ectopic decidual immunoreactivity with respect to the progression of labor at term and the lack of analogical changes in placental abruption," Am J Reprod Immunol, vol. 60, pp. 204-13, Sep 2008.
[10] A. Barone, O. Ebesh, R. G. Harper, and R. A. Wapnir, "Placental Copper Transport in Rats: Effects of Elevated Dietary Zinc on Fetal Copper, Iron and Metallothionein." vol. 128, 1998, pp. 1037-1041.
[11] K. G. Danielson, S. Ohi, and P. C. Huang, "Immunochemical detection of metallothionein in specific epithelial cells of rat organs," Proc Natl Acad Sci U S A, vol. 79, pp. 2301-4, Apr 1982.
[12] R. D. Andersen, J. E. Piletz, B. W. Birren, and H. R. Herschman, "Levels of metallothionein messenger RNA in foetal, neonatal and maternal rat liver," Eur J Biochem, vol. 131, pp. 497-500, Apr 5 1983.
[13] M. G. Cherian, D. M. Templeton, K. R. Gallant, and D. Banerjee, "Biosynthesis and metabolism of metallothionein in rat during perinatal development.," Experientia vol. 52:, pp. 499-505, 1987.
[14] P. Coyle, J. C. Philcox, L. C. Carey, and A. M. Rofe, "Metallothionein: the multipurpose protein," Cell Mol Life Sci, vol. 59, pp. 627-47, Apr 2002.
[15] R. J. Cousins, "Metallothionein--aspects related to copper and zinc metabolism," J Inherit Metab Dis, vol. 6 Suppl 1, pp. 15-21, 1983.
[16] N. Thirumoorthy, A. Shyam Sunder, K. Manisenthil Kumar, M. Senthil Kumar, G. Ganesh, and M. Chatterjee, "A review of metallothionein isoforms and their role in pathophysiology," World J Surg Oncol, vol. 9, p. 54, 2011.
[17] K. J. Waldron, J. C. Rutherford, D. Ford, and N. J. Robinson, "Metalloproteins and metal sensing," Nature, vol. 460, pp. 823-30, Aug 13 2009.
[18] P. Moffatt and F. Denizeau, "Metallothionein in physiological and physiopathological processes," Drug Metab Rev, vol. 29, pp. 261-307, Feb-May 1997.
[19] M. Sato and M. Kondoh, "Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals," Tohoku J Exp Med, vol. 196, pp. 9-22, Jan 2002.
[20] G. Isani and E. Carpenè, "Metallothioneins, Unconventional Proteins from Unconventional Animals: A Long Journey from Nematodes to Mammals." vol. 4, 2014, pp. 435-457.
[21] J. E. Piletz, R. D. Andersen, B. W. Birren, and H. R. Herschman, "Metallothionein synthesis in foetal, neonatal and maternal rat liver," Eur J Biochem, vol. 131, pp. 489-95, Apr 5 1983.
[22] M. P. Waalkes, A. M. Poisner, G. W. Wood, and C. D. Klaassen, "Metallothionein-like proteins in human placenta and fetal membranes," Toxicol Appl Pharmacol, vol. 74, pp. 179-84, Jun 30 1984.
[23] W. M. White, B. C. Brost, Z. Sun, C. Rose, I. Craici, S. J. Wagner, S. Turner, and V. D. Garovic, "Normal early pregnancy: a transient state of epigenetic change favoring hypomethylation," Epigenetics, vol. 7, pp. 729-34, Jul 2012.
[24] F. Gao, X. Ma, A. Rusie, J. Hemingway, A. B. Ostmann, D. Chung, and S. K. Das, "Epigenetic changes through DNA methylation contribute to uterine stromal cell decidualization," Endocrinology, vol. 153, pp. 6078-90, Dec.
[25] J. Tost, "DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker," Mol Biotechnol., vol. 44, pp. 71-81, 2010.
[26] H. Kurita, S. Ohsako, S. Hashimoto, J. Yoshinaga, and C. Tohyama, "Prenatal zinc deficiency-dependent epigenetic alterations of mouse metallothionein-2 gene," J Nutr Biochem, vol. 24, pp. 256-66, Jan 2013.
[27] H. Jakovac, D. Grebic, T. Grubic-Kezele, I. Mrakovcic-Sutic, D. Rukavina, and B. Radosevic-Stasic, "Endoplasmic reticulum resident heat shock protein-gp96 as morphogenetic and immunoregulatory factor in syngeneic pregnancy," Histol Histopathol, vol. 28, pp. 1285-98, Oct 2013.
[28] I. Mrakovcic-Sutic, M. Simin, D. Radic, D. Rukavina, and B. Radosevic-Stasic, "Syngeneic pregnancy induces overexpression of natural killer T cells in maternal liver," Scand J Immunol, vol. 58, pp. 358-66, Sep 2003.
[29] Keglević D, Ladešić B, Tomašić J, Valinger Z, and Naumski R, "Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant," Biochim. Biophys. Acta vol. 585 pp. 273-281, 1979.
[30] H. Jakovac, D. Grebic, M. Tota, V. Barac-Latas, I. Mrakovcic-Sutic, C. Milin, and B. Radosevic-Stasic, "Time-course expression of metallothioneins and tissue metals in chronic relapsing form of experimental autoimmune encephalomyelitis," Histol Histopathol, vol. 26, pp. 233-45, Feb 2011.
[31] B. R. Sonawane, M. Nordberg, G. F. Nordberg, and G. W. Lucier, "Placental transfer of cadmium in rats: influence of dose and gestational age," Environ Health Perspect, vol. 12, pp. 97-102, Dec 1975.
[32] B. L. Vallee, "Metallothionein: historical review and perspectives," Experientia Suppl, vol. 34, pp. 19-39, 1979.
[33] M. Margoshes and B. Vallee, "A cadmium protein from equine kidney cortex. ," J Am Chem Soc vol. 79:, pp. 4813-4814., 1957.
[34] S. R. Davis and R. J. Cousins, "Metallothionein Expression in Animals: A Physiological Perspective on Function." vol. 130: J Nutr. 2000 May;130(5):1085-8., 2000, pp. 1085-1088.
[35] L. Hou, X. Zhang, D. Wang, and A. Baccarelli, "Environmental chemical exposures and human epigenetics," Int J Epidemiol, vol. 41, pp. 79-105, Feb 2011.
[36] R. Martinez-Zamudio and H. C. Ha, "Environmental epigenetics in metal exposure," Epigenetics, vol. 6, pp. 820-7, Jul 2011.
[37] J. M. Greer and P. A. McCombe, "The role of epigenetic mechanisms and processes in autoimmune disorders," 2012.
[38] R. K. Yuen, M. S. Penaherrera, P. von Dadelszen, D. E. McFadden, and W. P. Robinson, "DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia," Eur J Hum Genet, vol. 18, pp. 1006-12, Sep 2010.
[39] H. C. Sorkun, F. Bir, M. Akbulut, U. Divrikli, G. Erken, H. Demirhan, E. Duzcan, L. Elci, I. Celik, and U. Yozgatli, "The effects of air pollution and smoking on placental cadmium, zinc concentration and metallothionein expression," Toxicology, vol. 238, pp. 15-22, Aug 16 2007.
[40] Y. Arnson, Y. Shoenfeld, and H. Amital, "Effects of tobacco smoke on immunity, inflammation and autoimmunity," J Autoimmun, vol. 34, pp. J258-65, May 2010.
[41] M. F. McAleer and R. S. Tuan, "Cytotoxicant-induced trophoblast dysfunction and abnormal pregnancy outcomes: role of zinc and metallothionein," Birth Defects Res C Embryo Today, vol. 72, pp. 361-70, 2004.
[42] Guerrero-Bosagna, "Environmental signal¬ing and evolutionary change: can exposure of pregnant mammals to environmental estrogens lead to epigenetically induced evolutionary changes in embryos? ," 2005.
[43] C. Guerrero-Bosagna, P. Sabat, and L. Valladares, "Environmental signaling and evolutionary change: can exposure of pregnant mammals to environmental estrogens lead to epigenetically induced evolutionary changes in embryos?," Evol Dev, vol. 7, pp. 341-50, Jul-Aug 2005.
[44] G. J. Burton and E. Jauniaux, "Placental Oxidative Stress: From Miscarriage to Preeclampsia," Journal of the Society for Gynecologic Investigation, vol. 11, pp. 342-352, 2004.
[45] L. Myatt, "Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta," Placenta, vol. 31, pp. S66-S69.
[46] S. L. Adamson, Y. Lu, K. J. Whiteley, D. Holmyard, M. Hemberger, C. Pfarrer, and J. C. Cross, "Interactions between Trophoblast Cells and the Maternal and Fetal Circulation in the Mouse Placenta," Developmental Biology, vol. 250, pp. 358-373, 2002.
[47] G. Chaouat, S. Zourbas, S. Ostojic, G. Lappree-Delage, S. Dubanchet, N. Ledee, and J. Martal, "A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy," Journal of Reproductive Immunology, vol. 53, pp. 241-256, 2002.
[48] D. Rukavina and T. J. Gill, 3rd, "Immunobiology and immunopathology of early pregnancy," Early Pregnancy, vol. 3, pp. 141-5, Jun 1997.
[49] S. Saito, A. Nakashima, T. Shima, and M. Ito, "REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T-Cell Paradigm in Pregnancy," American Journal of Reproductive Immunology, vol. 63, pp. 601-610, 2010.
[50] J. Szekeres-Bartho, M. Halasz, and T. Palkovics, "Progesterone in pregnancy; receptor-ligand interaction and signaling pathways," J Reprod Immunol, vol. 83, pp. 60-4, Dec 2009.
[51] R. P. Wallin, A. Lundqvist, S. H. More, A. von Bonin, R. Kiessling, and H. G. Ljunggren, "Heat-shock proteins as activators of the innate immune system," Trends Immunol, vol. 23, pp. 130-5, Mar 2002.
[52] K. Koga and G. Mor, "Review Article: Expression and Function of Toll-Like Receptors at the Maternal—Fetal Interface." vol. 15: Reprod. Sci., 2008, pp. 231-242.
[53] N. Štrbo, K. Yamazaki, K. Lee, D. Rukavina, and E. R. Podack, "Heat Shock Fusion Protein gp96-Ig Mediates Strong CD8 CTL Expansion in vivo," American Journal of Reproductive Immunology, vol. 48, pp. 220-225, 2002.
[54] D. G. Li, C. B. Gordon, C. A. Stagg, and R. Udelsman, "Heat shock protein expression in human placenta and umbilical cord," Shock, vol. 5, pp. 320-3, May 1996.
[55] G. K. Andrews, Y. M. Huet-Hudson, B. C. Paria, M. T. McMaster, S. K. De, and S. K. Dey, "Metallothionein gene expression and metal regulation during preimplantation mouse embryo development (MT mRNA during early development)," Dev Biol, vol. 145, pp. 13-27, May 1991.
[56] P. Lichtlen and W. Schaffner, "The "metal transcription factor" MTF-1: biological facts and medical implications," Swiss Med Wkly, vol. 131, pp. 647-52, Dec 1 2001.
[57] G. K. Andrews, D. K. Lee, R. Ravindra, P. Lichtlen, M. Sirito, M. Sawadogo, and W. Schaffner, "The transcription factors MTF-1 and USF1 cooperate to regulate mouse metallothionein-I expression in response to the essential metal zinc in visceral endoderm cells during early development," Embo J, vol. 20, pp. 1114-22, Mar 1 2001.
[58] L. Rink and H. Haase, "Zinc homeostasis and immunity," Trends Immunol, vol. 28, pp. 1-4, Jan 2007.
[59] A. S. Prasad, "Clinical, immunological, anti-inflammatory and antioxidant roles of zinc," Experimental Gerontology, vol. 43, pp. 370-377, 2008.
[60] E. Mocchegiani, M. Muzzioli, and R. Giacconi, "Zinc, metallothioneins, immune responses, survival and ageing," Biogerontology, vol. 1, pp. 133-43, 2000.
[61] L. Wicherek, K. Galazka, T. J. Popiela, M. Dutsch-Wicherek, A. Czekierdowski, W. Pabian, T. Banas, M. Migdal, and M. Klimek, "Metallothionein expression and infiltration of cytotoxic lymphocytes in uterine and tubal implantation sites," J Reprod Immunol, vol. 70, pp. 119-31, Jun 2006.
[62] H. Nishimura, N. Nishimura, and C. Tohyama, "Immunohistochemical localization of metallothionein in developing rat tissues," J Histochem Cytochem, vol. 37, pp. 715-22, May 1989.
[63] B. Ruttkay-Nedecky, L. Nejdl, J. Gumulec, O. Zitka, M. Masarik, T. Eckschlager, M. Stiborova, V. Adam, and R. Kizek, "The role of metallothionein in oxidative stress," Int J Mol Sci, vol. 14, pp. 6044-66, 2013.
[64] M. Capdevila, R. Bofill, O. Palacios, and S. Atrian, "State-of-the-art of metallothioneins at the beginning of the 21st century," Coordination Chemistry Reviews, vol. 256 pp. 46- 62, 2012.
[65] A. Swain, T. Inoue, K. S. Tan, Y. Nakanishi, and D. Sugiyama, "Intrinsic and extrinsic regulation of mammalian hematopoiesis in the fetal liver," Histol Histopathol, vol. 29, pp. 1077-82, Sep 2014.
[66] R. De Lisle, Sarras MP Jr, J. Hidalgo, and G. Andrews, "Metallothionein is a component of exocrine pancreas secretion: implications for zinc homeostasis. ," Am J Physiol., vol. 271, pp. 1103-10., 1996.
[67] J. E. Mullins and I. C. Fuentealba, "Immunohistochemical detection of metallothionein in liver, duodenum and kidney after dietary copper-overload in rats," Histol Histopathol, vol. 13, pp. 627-33, Jul 1998.
[68] T. Ayabe, D. P. Satchell, C. L. Wilson, W. C. Parks, M. E. Selsted, and A. J. Ouellette, "Secretion of microbicidal [alpha]-defensins by intestinal Paneth cells in response to bacteria," Nat Immunol, vol. 1, pp. 113-118, 2000.
[69] A. M. Ronco, F. Garrido, and M. N. Llanos, "Smoking specifically induces metallothionein-2 isoform in human placenta at term," Toxicology, vol. 223, pp. 46-53, Jun 1 2006.
Cite This Article
  • APA Style

    Hrvoje Jakovac, Damir Grebić, Ines Mrakovcic-Šutić, Daniel Rukavina, Biserka Radošević-Stašić. (2015). Expression of Metallothioneins in Placental and Fetal Tissues in Undisturbed and PGM-Zn Treated Syngeneic Pregnancy. American Journal of BioScience, 3(2-2), 1-7. https://doi.org/10.11648/j.ajbio.s.2015030202.12

    Copy | Download

    ACS Style

    Hrvoje Jakovac; Damir Grebić; Ines Mrakovcic-Šutić; Daniel Rukavina; Biserka Radošević-Stašić. Expression of Metallothioneins in Placental and Fetal Tissues in Undisturbed and PGM-Zn Treated Syngeneic Pregnancy. Am. J. BioScience 2015, 3(2-2), 1-7. doi: 10.11648/j.ajbio.s.2015030202.12

    Copy | Download

    AMA Style

    Hrvoje Jakovac, Damir Grebić, Ines Mrakovcic-Šutić, Daniel Rukavina, Biserka Radošević-Stašić. Expression of Metallothioneins in Placental and Fetal Tissues in Undisturbed and PGM-Zn Treated Syngeneic Pregnancy. Am J BioScience. 2015;3(2-2):1-7. doi: 10.11648/j.ajbio.s.2015030202.12

    Copy | Download

  • @article{10.11648/j.ajbio.s.2015030202.12,
      author = {Hrvoje Jakovac and Damir Grebić and Ines Mrakovcic-Šutić and Daniel Rukavina and Biserka Radošević-Stašić},
      title = {Expression of Metallothioneins in Placental and Fetal Tissues in Undisturbed and PGM-Zn Treated Syngeneic Pregnancy},
      journal = {American Journal of BioScience},
      volume = {3},
      number = {2-2},
      pages = {1-7},
      doi = {10.11648/j.ajbio.s.2015030202.12},
      url = {https://doi.org/10.11648/j.ajbio.s.2015030202.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbio.s.2015030202.12},
      abstract = {Metallothioneins (MTs) are cysteine-rich proteins, which have been implicated in regulation of physiological processes, such as cell growth, repair, differentiation, apoptosis and immunoregulation, as well as in the protection against heavy metals, oxidant damages, inflammation and other stressful conditions. To investigate their roles in physiological and detoxification processes at the maternal-fetal interface and in fetal organogenesis we examined the tissue expression of MT I/II isoforms in undisturbed syngeneic pregnancy and after the treatment with peptidoglycan monomer linked with zinc (PGM-Zn). The data showed that in undisturbed pregnancy the MTs were highly expressed at junctional zone of placenta, on endovascular trophoblast giant cells, glycogen cells and spongiotrophoblast cells, as well as on villous trophoblast cells. In the fetus they were found predominantly in the liver and in epithelial tissues, such as intestine, pancreas and kidney. Treatment with PGM-Zn markedly enhanced the intensity of MT staining both at the maternal-fetal interface and in fetal organs. The data imply that MTs are involved in the protection of trophoblast cells against the pregnancy-induced deregulation of redox and neuro-immuno-endocrine homeostasis, in transport and storage of essential metals required for fetal organogenesis, as well as in the protection of fetus against bacterial toxins.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Expression of Metallothioneins in Placental and Fetal Tissues in Undisturbed and PGM-Zn Treated Syngeneic Pregnancy
    AU  - Hrvoje Jakovac
    AU  - Damir Grebić
    AU  - Ines Mrakovcic-Šutić
    AU  - Daniel Rukavina
    AU  - Biserka Radošević-Stašić
    Y1  - 2015/03/02
    PY  - 2015
    N1  - https://doi.org/10.11648/j.ajbio.s.2015030202.12
    DO  - 10.11648/j.ajbio.s.2015030202.12
    T2  - American Journal of BioScience
    JF  - American Journal of BioScience
    JO  - American Journal of BioScience
    SP  - 1
    EP  - 7
    PB  - Science Publishing Group
    SN  - 2330-0167
    UR  - https://doi.org/10.11648/j.ajbio.s.2015030202.12
    AB  - Metallothioneins (MTs) are cysteine-rich proteins, which have been implicated in regulation of physiological processes, such as cell growth, repair, differentiation, apoptosis and immunoregulation, as well as in the protection against heavy metals, oxidant damages, inflammation and other stressful conditions. To investigate their roles in physiological and detoxification processes at the maternal-fetal interface and in fetal organogenesis we examined the tissue expression of MT I/II isoforms in undisturbed syngeneic pregnancy and after the treatment with peptidoglycan monomer linked with zinc (PGM-Zn). The data showed that in undisturbed pregnancy the MTs were highly expressed at junctional zone of placenta, on endovascular trophoblast giant cells, glycogen cells and spongiotrophoblast cells, as well as on villous trophoblast cells. In the fetus they were found predominantly in the liver and in epithelial tissues, such as intestine, pancreas and kidney. Treatment with PGM-Zn markedly enhanced the intensity of MT staining both at the maternal-fetal interface and in fetal organs. The data imply that MTs are involved in the protection of trophoblast cells against the pregnancy-induced deregulation of redox and neuro-immuno-endocrine homeostasis, in transport and storage of essential metals required for fetal organogenesis, as well as in the protection of fetus against bacterial toxins.
    VL  - 3
    IS  - 2-2
    ER  - 

    Copy | Download

Author Information
  • Department of Physiology and Immunology, Medical Faculty, University of Rijeka, Rijeka, Croatia

  • Croatian Academy of Sciences and Arts, Department of Clinical and Transplantation Immunology and Molecular Medicine, University of Rijeka, Rijeka, Croatia

  • Sections